Adial Pharmaceuticals (NASDAQ:ADIL) Posts Quarterly Earnings Results, Misses Estimates By $0.20 EPS
Adial Pharmaceuticals (NASDAQ:ADIL – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.59) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.39) by ($0.20), Zacks reports. Adial Pharmaceuticals Price Performance Shares of ADIL stock remained flat at $0.97 on Thursday. 167,506 shares of the stock traded […]
More Stories
Korro Bio, Inc. (NASDAQ:KRRO) Receives $142.17 Average Price Target from Brokerages
Korro Bio, Inc. (NASDAQ:KRRO – Get Free Report) has been assigned a consensus rating of “Buy” from the six ratings...
TD Securities Cuts Talon Metals (TSE:TLO) Price Target to C$0.30
Talon Metals (TSE:TLO – Free Report) had its price target decreased by TD Securities from C$0.55 to C$0.30 in a...
Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Free Report) in a report published on Monday morning....
Reading International (NASDAQ:RDI) Now Covered by StockNews.com
StockNews.com began coverage on shares of Reading International (NASDAQ:RDI – Free Report) in a report issued on Monday. The firm...
Symbolic Logic (NASDAQ:EVOL) Now Covered by StockNews.com
StockNews.com started coverage on shares of Symbolic Logic (NASDAQ:EVOL – Free Report) in a research report sent to investors on...
Remark (NASDAQ:MARK) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Remark (NASDAQ:MARK – Free Report) in a research report released on Monday. The firm...